A special grant for special patients from the American Cancer Society.
D000119:Acetylmuramyl-Alanyl-Isoglutamine / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000150:complications*; D005376:Financial Management / Q000191:economics*; D005382:Financing, Personal / Q000191:economics*; D005653:Fund Raising / Q000191:economics*; D006801:Humans; D008175:Lung Neoplasms / Q000191:economics / Q000556:secondary / Q000628:therapy*; D012516:Osteosarcoma / Q000150:complications*
D000119:Acetylmuramyl-Alanyl-Isoglutamine; C035104:muramylNAc-Ala-isoGln-Lys-tripeptide